Grünenthal and BCWorld Pharm Join Forces for Niche Pain Management Solution in South Korea Grünenthal partners with BCWorld Pharm for exclusive rights to Qutenza® in South Korea, expanding non-opioid pain management solutions across Asia.

Grünenthal and BCWorld Pharm Join Forces for Niche Pain Management Solution in South Korea #South_Korea #Grünenthal #Qutenza #BCWorld_Pharm #Yeoju

Grünenthal Fully Acquires Grünenthal Meds, Strengthening Its Market Position Grünenthal has successfully taken full ownership of Grünenthal Meds from Kyowa Kirin, enhancing its reach in established medicine markets across 60+ regions.

Grünenthal Fully Acquires Grünenthal Meds, Strengthening Its Market Position #Germany #Grünenthal #Aachen #Kyowa_Kirin #Grünenthal_Meds

Grünenthal Partners with Clinect to Introduce Qutenza in Australia Grünenthal has signed an agreement with Clinect to grant exclusive Australian rights to the Qutenza patch, a non-opioid treatment for neuropathic pain.

Grünenthal Partners with Clinect to Introduce Qutenza in Australia #Australia #Victoria #Grünenthal #Qutenza #Clinect

Grünenthal's NaV 1.8 Inhibitor Advances to Clinical Trials Aiming for Non-Opioid Pain Relief Grünenthal has commenced a Phase I trial for its NaV 1.8 inhibitor, a promising non-opioid therapy for acute and chronic pain. Initial results are anticipated in late 2026.

Grünenthal's NaV 1.8 Inhibitor Advances to Clinical Trials Aiming for Non-Opioid Pain Relief #Germany #Clinical_Trial #Grünenthal #Aachen #NaV_1.8

Grünenthal Partners with Apotex for Testosterone Therapy Nebido® in Canada Grünenthal has struck a deal with Apotex to license Nebido® for testosterone replacement in Canada, enhancing patient access and treatment options.

Grünenthal Partners with Apotex for Testosterone Therapy Nebido® in Canada #Canada #Toronto #Grünenthal #Apotex #Nebido

Apotex Secures Exclusive Canadian Rights for Testerone Therapy Nebido® from Grünenthal Apotex has obtained exclusive rights to market Nebido®, a testosterone replacement therapy, in Canada from Grünenthal. This partnership will enhance access to treatments for men's health.

Apotex Secures Exclusive Canadian Rights for Testerone Therapy Nebido® from Grünenthal #Canada #Toronto #Grünenthal #Apotex #Nebido

#Contergan und die #Grünenthal GmbH

Grünenthal PRO Teams Up with SHL Medical for Enhanced Autoinjector Assembly Grünenthal PRO partners with SHL Medical to boost its autoinjector assembly services, enhancing supply chain efficiencies and offering faster market solutions for pharmaceuticals.

Grünenthal PRO Teams Up with SHL Medical for Enhanced Autoinjector Assembly #Germany #Grünenthal #Aachen #SHL_Medical #Molly_Autoinjector

#contergan
#grünenthal

youtube.com/shorts/D1z6a...

Grünenthal reduce un 20% su huella de carbono por tercer año consecutivo - Corresponsables Grünenthal reduce un 20 % su huella de carbono por tercer año consecutivo y publica su 8ª Memoria de Sostenibilidad, reforzando su compromiso con el planeta, las personas y los pacientes

🌱 #Grünenthal reduce su #HuelladeCarbono un 20 % por 3er año y refuerza su compromiso con personas, pacientes y planeta

💚 Nueva #MemoriaSostenibilidad ya disponible 👇

Todos los detalles en #Corresponsables 👉 www.corresponsables.com/actualidad/g...

#GrünenthalPharma #Sostenibilidad #Salud

Opioid-Krise in Deutschland? - Gute Pillen - Schlechte Pillen Der Anbieter Grünenthal bewirbt Tapentadol als wirksamer und sicherer als andere Opioide – dafür fehlen aber überzeugende Daten.

In #Deutschland gebe es keine Hinweise auf eine so genannte #Opioid-Krise wie in den #USA. Der Anbieter #Grünenthal bewirbt #Tapentadol als wirksamer und sicherer als andere #Opioide – dafür fehlen aber überzeugende Daten 💊 (€)

Aus dem gleichen Grund ist #Grünenthal übrigens auch mit #Zalviso gescheitert. #Rohrkrepierer #habichdochgleichgesagt

Grünenthal Enhances Global Regulatory Information Management with Veeva RIM Grünenthal has announced their collaboration with Veeva Systems to improve global regulatory management and operations, enhancing drug delivery for patients.

Grünenthal Enhances Global Regulatory Information Management with Veeva RIM #Germany #Barcelona #Pain_Management #Grünenthal #Veeva_RIM

Grünenthal Enhances Global Regulatory Management with Veeva's RIM Solution Grünenthal is set to revolutionize its regulatory landscape by adopting Veeva's RIM, improving compliance and efficiency in drug delivery.

Grünenthal Enhances Global Regulatory Management with Veeva's RIM Solution #Spain #Barcelona #Grünenthal #Veeva #RIM

Grünenthal Strengthens Global Regulatory Information Management with Veeva RIM Grünenthal enhances its global regulatory capabilities using Veeva RIM, streamlining processes to accelerate drug delivery for patients in need.

Grünenthal Strengthens Global Regulatory Information Management with Veeva RIM #USA #Barcelona #Grünenthal #Veeva_RIM #Regulatory_Management

Grünenthal Enhances Global Regulatory Information Management with Veeva RIM Grünenthal is leveraging Veeva RIM to streamline its global regulatory processes, enhancing efficiency and collaboration to accelerate drug delivery.

Grünenthal Enhances Global Regulatory Information Management with Veeva RIM #USA #Barcelona #Grünenthal #Veeva #RIM

Maßnahmen gegen den Fachkräftemangel Berufundfamilie zertifiziert Unternehmen, die in familien- und lebensphasenbewusste Maßnahmen zur Personalbindung investieren.

Wie #Pharmaunternehmen mit #vereinbarkeit|sfördernden Angeboten dem #Fachkräftemangel Contra bieten? #Grünenthal #Pharma GmbH & Co.KG und #DRKADE #HealthCare verraten es im Artikel für phpro: t1p.de/ft21h !B #worklifebalance #personalpolitik

Grünenthal Strengthens Presence in Latin America with Cialis® Acquisition from Eli Lilly Grünenthal has officially acquired the rights to Cialis® from Eli Lilly for distribution in Mexico, Brazil, and Colombia, enhancing its product portfolio.

Grünenthal Strengthens Presence in Latin America with Cialis® Acquisition from Eli Lilly #Germany #Eli_Lilly #Grünenthal #Aachen #Cialis

Maren Thurow Takes Charge as New Head of Global Communications at Grünenthal Maren Thurow has stepped into her new role as the Vice President and Head of Global Communications at Grünenthal, taking over from Florian Dieckmann.

Maren Thurow Takes Charge as New Head of Global Communications at Grünenthal #Germany #Communications #Grünenthal #Aachen #Maren_Thurow

Dirk hat sich dabei ein paar relevante Orte ansehen können, wie den #Jubiläumswald, den #Stadtpark, die #Grundschule #Wiehagen, sowie die Flächen für die Einfach- und die eventuelle #Dreifachhalle im #Grünenthal. 2/2

Sigrid Nachtigahl, Senior HR Manager Work&Life berichtet aus über einem Jahrzehnt Engagement für die Vereinbarkeit von Beruf, Familie und Privatleben (Quelle: Grünenthal)

Wie gelingt strategische #Vereinbarkeit bei einem mittelständischen #Pharma|-Unternehmen? Sigrid Nachtigahl von #Grünenthal, zertifizert nach dem #auditberufundfamilie seit 2011, liefert uns Antworten im Blog-Interview: rb.gy/3741p3 !B.

Apotex and Grünenthal Collaborate for Exclusive Pain Management Rights in Canada Apotex has secured exclusive rights to Qutenza® from Grünenthal, enhancing options for neuropathic pain treatment in Canada. This partnership aims to improve patient care and expand drug availability.

Apotex and Grünenthal Collaborate for Exclusive Pain Management Rights in Canada #Canada #Toronto #Grünenthal #Apotex #Qutenza

Apotex Secures Exclusive Rights to Qutenza® for Canadian Market from Grünenthal Apotex has recently licensed exclusive Canadian rights to Qutenza®, a revolutionary pain patch from Grünenthal, enhancing options for neuropathic pain management.

Apotex Secures Exclusive Rights to Qutenza® for Canadian Market from Grünenthal #Canada #Toronto #Grünenthal #Apotex #Qutenza®

Grünenthal Announces Appointment of Prof. Dr. Uli Brödl as New Chief Scientific Officer Grünenthal has appointed Prof. Dr. Uli Brödl as its new Chief Scientific Officer. He brings over 15 years of experience, aiming to enhance the company's innovative approaches in pain management.

Grünenthal Announces Appointment of Prof. Dr. Uli Brödl as New Chief Scientific Officer #Germany #Grünenthal #Uli_Brödl #Chief_Scientific_Officer #Aachen

31.08.2012: Der frühere #Contergan-Hersteller #Grünenthal entschuldigt sich erstmals explizit bei den Opfern des Arzneimittelskandals.

Eine doch sehr seltsame Begegnung mit dem @Haekelschwein

Superhelden unter sich: http://twitpic.com/10bwb7 (Bild: @2gel) #Grünenthal